C20ORF118 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.576000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.057400E-01
Normal-vs-Stage2
2.494200E-01
Normal-vs-Stage3
5.146200E-01
Normal-vs-Stage4
4.307600E-01
Stage1-vs-Stage2
5.158400E-01
Stage1-vs-Stage3
7.538200E-01
Stage1-vs-Stage4
4.613600E-01
Stage2-vs-Stage3
9.523800E-01
Stage2-vs-Stage4
5.251400E-01
Stage3-vs-Stage4
7.389600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.747400E-01
Normal-vs-AfricanAmerican
7.758100E-02
Normal-vs-Asian
2.545000E-01
Caucasian-vs-AfricanAmerican
1.246180E-01
Caucasian-vs-Asian
2.714200E-01
AfricanAmerican-vs-Asian
6.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.413200E-01
Normal-vs-Female
2.832400E-01
Male-vs-Female
2.151400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.842800E-01
Normal-vs-Age(41-60Yrs)
1.821970E-01
Normal-vs-Age(61-80Yrs)
3.183800E-01
Normal-vs-Age(81-100Yrs)
2.069600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.318200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.563200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.514400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.898820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.513200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.746190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.889800E-01
Normal-vs-Daily Drinker
3.903200E-01
Normal-vs-Weekly Drinker
4.671600E-01
Normal-vs-Occasional Drinker
3.221800E-01
Normal-vs-Social Drinker
4.654400E-01
Non Drinker-vs-Daily Drinker
8.740500E-02
Non Drinker-vs-Weekly Drinker
1.038160E-01
Non Drinker-vs-Occasional Drinker
1.312570E-01
Non Drinker-vs-Social Drinker
4.666200E-01
Daily Drinker-vs-Weekly Drinker
8.047800E-01
Daily Drinker-vs-Occasional Drinker
8.958600E-01
Daily Drinker-vs-Social Drinker
6.034600E-01
Weekly Drinker-vs-Occasional Drinker
7.137200E-01
Weekly Drinker-vs-Social Drinker
5.118600E-01
Occasional Drinker-vs-Social Drinker
6.606800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.633180E-01
Normal-vs-Grade 2
1.396450E-01
Normal-vs-Grade 3
2.175000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.062200E-01
Grade 1-vs-Grade 3
9.953600E-01
Grade 1-vs-Grade 4
1.633180E-01
Grade 2-vs-Grade 3
3.280400E-01
Grade 2-vs-Grade 4
1.396450E-01
Grade 3-vs-Grade 4
2.175000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.900600E-01
Normal-vs-NonDiabetic
2.575600E-01
Diabetic-vs-NonDiabetic
1.260400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.913800E-01
Normal-vs-NoPancreatitis
2.899200E-01
Pancreatitis-vs-NoPancreatitis
7.313200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.219600E-01
Normal-vs-N1
2.705400E-01
N0-vs-N1
1.789440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.164800E-01
Normal-vs-TP53-NonMutant
2.017000E-03
TP53-Mutant-vs-TP53-NonMutant
2.988400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
